Apogee Therapeutics (APGE) has an average rating of overweight and mean price target of $119.07, according to analysts polled by FactSet.
Price: $132.65, Change: $+42.27, Percent Change: +46.76%
What else is happening in Research?
Research
Goodbody Boosts Wizz Air PT, Affirms Sell Rating
Goodbody on Friday increased the price target for budget airline company Wizz Air (WIZZ.L) to 10 pounds sterling from 6.30 pounds, while maintaining its sell rating.
$WIZZ.L
Research
Sadif Investment Analytics Downgrades Bayer to Sell, Lifts PT
Sadif Investment Analytics on Thursday downgraded German drugmaker Bayer (BAYN.F) to sell from hold and increased its price target to 39.70 euros from 38.20 euros.
$BAYN.F
Research
AlphaValue/Baader Europe Cuts Mercedes-Benz PT, Keeps at Reduce
AlphaValue/Baader Europe on Friday decreased the price target for German automaker Mercedes-Benz Group (MBG.F) to 45.20 euros from 52.00 euros and affirmed its rating at reduce.
$MBG.F